Serum protein S100A9, SOD3, and MMP9 as new diagnostic biomarkers for pulmonary tuberculosis by iTRAQ-coupled two-dimensional LC-MS/MS

Proteomics

Volumn 15, Issue 1, 2015, Pages 58-67

  Xu, Dandan ^a   Li, Yanyuan ^a   Li, Xiang ^b   Wei, Li Liang ^c   Pan, Zhifen ^d   Jiang, Ting Ting ^a   Chen, Zhong Liang ^a   Wang, Chong ^a   Cao, Wen Ming ^e   Zhang, Xing ^a   Ping, Ze Peng ^a   Liu, Chang Ming ^a   Liu, Ji Yan ^a   Li, Zhong Jie ^a   Li, Ji Cheng ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c Sixth Hospital of Shaoxing   (China)

^d Jiaxing First Hospital   (China)

^e ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

Cell biology; MMP9; Potential biomarkers; Pulmonary tuberculosis; S100A9; SOD3

Indexed keywords

BIOLOGICAL MARKER; CALGRANULIN B; EXTRACELLULAR SUPEROXIDE DISMUTASE; GELATINASE B; SOD3 PROTEIN, HUMAN; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; ISOBARIC TAGS FOR RELATIVE AND ABSOLUTE QUANTITATION; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; LUNG CANCER; LUNG DISEASE; LUNG TUBERCULOSIS; MALE; PNEUMONIA; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; BLOOD; LIQUID CHROMATOGRAPHY; MIDDLE AGED; PROTEOMICS; TANDEM MASS SPECTROMETRY; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ADULT; AGED; BIOLOGICAL MARKERS; CALGRANULIN B; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PROTEOMICS; SUPEROXIDE DISMUTASE; TANDEM MASS SPECTROMETRY; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84920628894     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201400366     Document Type: Article

References (47)

1. Frieden, T. R., Sterling, T. R., Munsiff, S. S., Watt, C. J., Dye, C., Tuberculosis. Lancet 2003, 362, 887-899.
2. World Health Orgnization. Global tuberculosis report 2013. WHO, Geneva, Switzerland 2013.
3. Wallis, R. S., Pai, M., Menzies, D., Doherty, T. M. et al., Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 2010, 375, 1920-1937.
4. Sreeramareddy, C. T., Panduru, K. V., Menten, J., Van den Ende, J., Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature. BMC Infect. Dis. 2009, 9, 91. doi: 10.1186/1471-2334-9-91.
5. Small, P. M., Pai, M., Tuberculosis diagnosis-time for a game change. N. Engl. J. Med. 2010, 363, 1070-1071.
6. Lange, C., Mori, T., Advances in the diagnosis of tuberculosis. Respirology 2010, 15, 220-240.
7. Ray, S., Reddy, P. J., Jain, R., Gollapalli, K. et al., Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead. Proteomics 2011, 11, 2139-2161.
8. Karp, N. A., Huber, W., Sadowski, P. G., Charles, P. D. et al., Addressing accuracy and precision issues in iTRAQ quantitation. Mol. Cell. Proteomics 2010, 9, 1885-1897.
9. Xu, D. D., Deng, D. F., Li, X., Wei, L. L. et al., Discovery and identification of serum potential biomarkers for pulmonary tuberculosis using iTRAQ-coupled two-dimensional LC-MS/MS. Proteomics 2014, 14, 322-331.
10. Chen, G., Zhang, Y., Jin, X., Zhang, L. et al., Urinary proteomics analysis for renal injury in hypertensive disorders of pregnancy with iTRAQ labeling and LC-MS/MS. Proteomics Clin. Appl. 2011, 5, 300-310.
11. Wang, Y. S., Cao, R., Jin, H., Huang, Y. P. et al., Altered protein expression in serum from endometrial hyperplasia and carcinoma patients. J. Hematol. Oncol. 2011, 4, 15. doi: 10.1186/1756-8722-4-15.
12. Jin, G. Z., Li, Y., Cong, W. M., Yu, H. et al., iTRAQ-2DLC-ESI-MS/MS based identification of a new set of immunohistochemical biomarkers for classification of dysplastic nodules and small hepatocellular carcinoma. J. Proteome. Res. 2011, 10, 3418-3428.
13. Xiao, Z., Li, G., Chen, Y., Li, M. et al., Quantitative proteomic analysis of formalin-fixed and paraffin-embedded nasopharyngeal carcinoma using iTRAQ labeling, two-dimensional liquid chromatography, and tandem mass spectrometry. J. Histochem. Cytochem. 2010, 58, 517-527.
14. Ye, H., Sun, L., Huang, X., Zhang, P., Zhao, X., A proteomic approach for plasma biomarker discovery with 8-plex iTRAQ labeling and SCX-LC-MS/MS. Mol. Cell. Biochem. 2010, 343, 91-99.
15. Liu, J. Y., Jin, L., Zhao, M. Y., Zhang, X. et al., New serum biomarkers for detection of tuberculosis using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Clin. Chem. Lab. Med. 2011, 49, 1727-1733.
16. Tarhan, G., Gumuslu, F., Yilmaz, N., Saka, D. et al., Serum adenosine deaminase enzyme and plasma platelet factor 4 activities in active pulmonary tuberculosis, HIV-seropositive subjects and cancer patients. J. Infect. 2006, 52, 264-268.
17. Herd, C. M., Page, C. P., Pulmonary immune cells in health and disease: platelets. Eur. Respir. J. 1994, 7, 1145-1160.
18. Leimeister, C., Schumacher, N., Diez, H., Gessler, M., Cloning and expression analysis of the mouse stroma marker Snep encoding a novel nidogen domain protein. Dev. Dyn. 2004, 230, 371-377.
19. Naba, A., Clauser, K. R., Lamar, J. M., Carr, S. A., Hynes, R. O., Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters. Elife 2014, 3, e01308.
20. Zhong, Z., Yeow, W. S., Zou, C., Wassell, R. et al., Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells. Cancer Res. 2010, 70, 2105-2114.
21. Shi, M., Cui, J., Du, J., Wei, D. et al., A novel KLF4/LDHA signaling pathway regulates aerobic glycolysis in and progression of pancreatic cancer. Clin. Cancer Res. 2014, 20, 4370-4380.
22. Visse, R., Nagase, H., Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 2003, 92, 827-839.
23. Volkman, H. E., Pozos, T. C., Zheng, J., Davis, J. M. et al., Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science 2010, 327, 466-469.
24. Ramakrishnan, L., Revisiting the role of the granuloma in tuberculosis. Nat. Rev. Immunol. 2012, 12, 352-366.
25. Park, K. J., Hwang, S. C., Sheen, S. S., Oh, Y. J. et al., Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer. Respiration 2005, 72, 166-175.
26. Sheen, P., O'Kane, C. M., Chaudhary, K., Tovar, M. et al., High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation. Eur. Respir. J. 2009, 33, 134-141.
27. Matsuura, E., Umehara, F., Hashiguchi, T., Fujimoto, N. et al., Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis. J. Neurol. Sci. 2000, 173, 45-52.
28. Hrabec, E., Strek, M., Zieba, M., Kwiatkowska, S., Hrabec, Z., Circulation level of matrix metalloproteinase-9 is correlated with disease severity in tuberculosis patients. Int. J. Tuberc. Lung Dis. 2002, 6, 713-719.
29. Foell, D., Wittkowski, H., Vogl, T., Roth, J., S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol. 2007, 81, 28-37.
30. Gopal, R., Monin, L., Torres, D., Slight, S. et al., S100A8/A9 Proteins Mediate Neutrophilic Inflammation and Lung Pathology during Tuberculosis. Am. J. Respir. Crit. Care Med. 2013, 188, 1137-1146.
31. Isaksen, B., Fagerhol, M. K., Calprotectin inhibits matrix metalloproteinases by sequestration of zinc. Mol. Pathol. 2001, 54, 289-292.
32. Greenlee, K. J., Corry, D. B., Engler, D. A., Matsunami, R. K. et al., Proteomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation. J. Immunol. 2006, 177, 7312-7321.
33. Markowitz, J., Carson, W. E., 3rd, Review of S100A9 biology and its role in cancer. Biochim. Biophys. Acta 2013, 1835, 100-109.
34. Rodriguez-Pineiro, A. M., Blanco-Prieto, S., Sanchez-Otero, N., Rodriguez-Berrocal, F. J., de la Cadena, M. P., On the identification of biomarkers for non-small cell lung cancer in serum and pleural effusion. J. Proteomics 2010, 73, 1511-1522.
35. Castellazzi, M., Tamborino, C., De Santis, G., Garofano, F. et al., Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage. Acta. Neurochir. Suppl. 2010, 106, 137-140.
36. van Zoelen, M. A., Vogl, T., Foell, D., Van Veen, S. Q. et al., Expression and role of myeloid-related protein-14 in clinical and experimental sepsis. Am. J. Respir. Crit. Care Med. 2009, 180, 1098-1106.
37. Pieters, J., Mycobacterium tuberculosis and the macrophage: maintaining a balance. Cell Host Microbe 2008, 3, 399-407.
38. Nozik-Grayck, E., Suliman, H. B., Piantadosi, C. A., Extracellular superoxide dismutase. Int. J. Biochem. Cell Biol. 2005, 37, 2466-2471.
39. Gao, F., Koenitzer, J. R., Tobolewski, J. M., Jiang, D. et al., Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan. J. Biol. Chem. 2008, 283, 6058-6066.
40. Wang, X. F., Wu, Y. H., Jiao, J., Guan, C. P. et al., Diagnostic value of superoxide dismutase in tuberculous and malignant pleural effusions. Asian Pac. J. Cancer Prev. 2013, 14, 821-824.
41. Durak, I., Canbolat, O., Kavutcu, M., Ozturk, H. S., Yurtarslani, Z., Activities of total, cytoplasmic, and mitochondrial superoxide dismutase enzymes in sera and pleural fluids from patients with lung cancer. J. Clin. Lab Anal. 1996, 10, 17-20.
42. Steingart, K. R., Dendukuri, N., Henry, M., Schiller, I. et al., Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis. Clin. Vaccine Immunol. 2009, 16, 260-276.
43. Steingart, K. R., Henry, M., Laal, S., Hopewell, P. C. et al., Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. PLoS Med. 2007, 4, e202.
44. Fu, T., Xie, J., Progress on the biomarkers for tuberculosis diagnosis. Crit. Rev. Eukaryot. Gene Expr. 2011, 21, 379-391.
45. Morris, K., WHO recommends against inaccurate tuberculosis tests. Lancet 2011, 377, 113-114.
46. Demir, T., Yalcinoz, C., Keskinel, I., Demiroz, F., Yildirim, N., sICAM-1 as a serum marker in the diagnosis and follow-up of treatment of pulmonary tuberculosis. Int. J. Tuberc. Lung Dis. 2002, 6, 155-159.
47. Agranoff, D., Fernandez-Reyes, D., Papadopoulos, M. C., Rojas, S. A. et al., Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 2006, 368, 1012-1021.